← board
CDIOW
distress 5/10 · elevated risk$0.01-6%today-65% from 52w high
Revenue
pre-revenue
Liquidity
$0M
Runway
—
Shares 1y
+68%
Price & events
-62.4% over 6M
CatalystRating changeDilutionFinancingdashed = today
-6.2%
1D
-21.1%
1W
-52.4%
1M
-52.4%
3M
—
6M
—
1Y
—
2Y
—
5Y
-62.4%
All
Overview
- Market Cap
- $35.51K
- Volume
- 1.20K
- 52 Week Range
- $0.01 – $0.03
- Total Shares
- 2.96M
- Float Shares
- 2.83M
- RVOL
- 1.70x
- Beta
- 2.18
Pipeline · 0 trials · 0 upcoming
| Readout | Phase | Drug | Indication | Enroll | Status |
|---|---|---|---|---|---|
| No pipeline trials tracked. | |||||
Catalyst news & presentations · 0
- No catalyst news yet.
Approved drugs (0)
- none — clinical-stage
Capital structure — dilution & financing
🔒 Top holders — Pro
Institutional ownership + quarter-over-quarter accumulation/trimming.
Upgrade to ProWall St ratings
no consensus
- no recent rating changes
Competitors
- none identified
Recent news
- none
Not financial advice. Data: ClinicalTrials.gov, SEC EDGAR, FINRA, Nasdaq, Yahoo.